Acorah Software Products - Accounts Production 15.0.600 false true 30 November 2022 1 December 2021 false 1 December 2022 30 November 2023 30 November 2023 07924432 Mrs Divya Patel Mr Harshad Patel Mr Mitul Patel iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 07924432 2022-11-30 07924432 2023-11-30 07924432 2022-12-01 2023-11-30 07924432 frs-core:SharePremium 2023-11-30 07924432 frs-core:ShareCapital 2023-11-30 07924432 frs-core:RetainedEarningsAccumulatedLosses 2023-11-30 07924432 frs-bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 07924432 frs-bus:FilletedAccounts 2022-12-01 2023-11-30 07924432 frs-bus:SmallEntities 2022-12-01 2023-11-30 07924432 frs-bus:AuditExempt-NoAccountantsReport 2022-12-01 2023-11-30 07924432 frs-bus:SmallCompaniesRegimeForAccounts 2022-12-01 2023-11-30 07924432 frs-core:CostValuation 2022-11-30 07924432 frs-core:CostValuation 2023-11-30 07924432 frs-core:ProvisionsForImpairmentInvestments 2022-11-30 07924432 frs-core:ProvisionsForImpairmentInvestments 2023-11-30 07924432 frs-bus:Director1 2022-12-01 2023-11-30 07924432 frs-bus:Director2 2022-12-01 2023-11-30 07924432 frs-bus:Director3 2022-12-01 2023-11-30 07924432 frs-countries:NorthernIreland 2022-12-01 2023-11-30 07924432 2021-11-30 07924432 2022-11-30 07924432 2021-12-01 2022-11-30 07924432 frs-core:SharePremium 2022-11-30 07924432 frs-core:ShareCapital 2022-11-30 07924432 frs-core:RetainedEarningsAccumulatedLosses 2022-11-30
Registered number: 07924432
Pharmaco (Suffolk) Limited
Financial Statements
For The Year Ended 30 November 2023
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2
Page 1
Balance Sheet
Registered number: 07924432
2023 2022
Notes £ £ £ £
FIXED ASSETS
Investments 4 3,812,767 3,812,767
3,812,767 3,812,767
TOTAL ASSETS LESS CURRENT LIABILITIES 3,812,767 3,812,767
NET ASSETS 3,812,767 3,812,767
CAPITAL AND RESERVES
Called up share capital 2,332 2,332
Share premium account 1,330,668 1,330,668
Profit and Loss Account 2,479,767 2,479,767
SHAREHOLDERS' FUNDS 3,812,767 3,812,767
For the year ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Harshad Patel
Director
13 August 2024
The notes on page 2 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Pharmaco (Suffolk) Limited is a private company, limited by shares, incorporated in Northern Ireland, registered number 07924432 . The registered office is Hunts Pharmacy, 205 Plumstead Road, Norwich, Norfolk, NR1 4AB.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Provisions
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 3 (2022: 3)
3 3
4. Investments
Subsidiaries
£
Cost
As at 1 December 2022 3,812,767
As at 30 November 2023 3,812,767
Provision
As at 1 December 2022 -
As at 30 November 2023 -
Net Book Value
As at 30 November 2023 3,812,767
As at 1 December 2022 3,812,767
Details of undertakings
Details of investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:
Undertaking                                                  Holding                           Proporation of voting rights &shares held
Subsidiary undertakings
Mid Suffolk Medical Supplies Limited            Ordinary shares              100%
Registered office
C/o Hunts Pharmacy, 205 Plumstead Road, Norwich, Norfolk, United Kingdom, NR1 4AB
The principal activity of Mid Suffolk Medical Supplies Limited is supply medicines and other goods as a pharmacy.
The profit for the financial period of Mid Suffolk Medical Supplies Limited was £417,864.00 and the aggregate amount of capital and reserves  at the end of the period was £4,514,291.00
5. Related Party Transactions
Mid Suffolk Medical Supplies Limited
( Company associated with the directors )
The directors of the company are also directors of Mid Suffolk Medical Supplies Limited.
During the the year company owed to Mid Suffolk Medical Supplies Limited was £0.00 (2022: £0.00).  The balance is interest free and repayble on demand.
Page 2